Hemostemix Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
01 May 24 | BuyCA$1,600 | Thomas Smeenk | Individual | 40,000 | CA$0.04 | |
14 Dec 23 | BuyCA$1,400 | Thomas Smeenk | Individual | 20,000 | CA$0.07 | |
05 Dec 23 | BuyCA$910 | Thomas Smeenk | Individual | 13,000 | CA$0.07 | |
08 Nov 23 | BuyCA$4,800 | Thomas Smeenk | Individual | 60,000 | CA$0.08 | |
07 Nov 23 | BuyCA$1,750 | Thomas Smeenk | Individual | 25,000 | CA$0.07 | |
02 Nov 23 | BuyCA$6,500 | Thomas Smeenk | Individual | 100,000 | CA$0.065 | |
01 Nov 23 | BuyCA$3,500 | Thomas Smeenk | Individual | 50,000 | CA$0.07 |
Insider Trading Volume
Insider Buying: HEM insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 150,000 | 0.172% |
Individual Insiders | 12,489,509 | 14.3% |
General Public | 74,482,809 | 85.5% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 7.4%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
6,096,214 | CA$213.4k | 0% | no data | |||
4,026,445 | CA$140.9k | 4.68% | no data | |||
1,800,593 | CA$63.0k | 2.27% | no data | |||
566,257 | CA$19.8k | 0% | no data | |||
150,000 | CA$5.2k | 0% | no data |